BridgeBio Pharma Inc (BBIO)
25.78
-1.05
(-3.91%)
USD |
NASDAQ |
Apr 15, 16:00
25.79
+0.01
(+0.04%)
After-Hours: 20:00
BridgeBio Pharma Total Liabilities (Quarterly): 1.889B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.889B |
| September 30, 2023 | 1.849B |
| June 30, 2023 | 1.853B |
| March 31, 2023 | 1.839B |
| December 31, 2022 | 1.868B |
| September 30, 2022 | 1.859B |
| June 30, 2022 | 1.877B |
| March 31, 2022 | 1.854B |
| December 31, 2021 | 1.878B |
| September 30, 2021 | 1.517B |
| June 30, 2021 | 1.537B |
| Date | Value |
|---|---|
| March 31, 2021 | 1.481B |
| December 31, 2020 | 595.70M |
| September 30, 2020 | 569.31M |
| June 30, 2020 | 577.72M |
| March 31, 2020 | 537.73M |
| December 31, 2019 | 155.70M |
| September 30, 2019 | 116.26M |
| June 30, 2019 | 593.09M |
| March 31, 2019 | 90.71M |
| December 31, 2018 | 87.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
116.26M
Minimum
Sep 2019
1.889B
Maximum
Dec 2023
1.287B
Average
1.537B
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 137.21B |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Ardelyx Inc | 130.76M |
| Regenxbio Inc | 262.23M |
| IDEAYA Biosciences Inc | 28.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 546.38M |
| Shareholders Equity (Quarterly) | -1.354B |
| Debt to Equity Ratio | -1.275 |
| Current Ratio | 3.320 |
| Net Debt Paydown Yield | -0.08% |